Structure-Based Drug Design of an Inhibitor of the SARS-CoV-2 (COVID-19) Main Protease Using Free Software: A Tutorial for Students and Scientists

Mostrar otras versiones (1)

This paper describes the structure-based design of a preliminary drug candidate against COVID-19 using free software and publicly available X-ray crystallographic structures. The goal of this tutorial is to disseminate skills in structure-based drug design and to allow others to unleash their own cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Sheng, Krumberger, Maj, Morris, Michael A., Parrocha, Chelsea Marie T., Griffin, James H., Kreutzer, Adam G., Nowick, James S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ChemRxiv 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430054/
https://www.ncbi.nlm.nih.gov/pubmed/32817929
http://dx.doi.org/10.26434/chemrxiv.12791954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430054/
https://www.ncbi.nlm.nih.gov/pubmed/32817929
http://dx.doi.org/10.26434/chemrxiv.12791954

Ejemplares similares